CUTILLASLAB · CSIC · GRANADA

Mapping the
circuitry of cancer.

We investigate how oncogenic signalling networks are wired, rewired and exploited by cancer cells — and how this circuitry shapes therapeutic response.

CutillasLab scientific logo
THE QUESTION

How are signalling networks wired in cancer?

Cancer cells do not rely on isolated pathways. They adapt through interconnected signalling circuits that integrate genetic, epigenetic and environmental information.

Our goal is to measure this circuitry directly. We combine functional perturbation, mass-spectrometry-based proteomics and computational biology to understand signalling heterogeneity, identify mechanisms of therapeutic resistance and uncover actionable vulnerabilities.

OUR APPROACH

Three perspectives.
One signalling network.

01

Functional screening

Perturb cancer cells at scale and measure viability, drug response, dependencies and combination effects.

Discover the approach →
03

Computational biology

Infer kinase activity, signalling circuitry and response signatures from complex proteomic and functional datasets.

See our research →
Signalling network
FROM DATA TO MECHANISM

Going beyond pathway diagrams.

Standard omics measurements tell us which molecules change. We want to understand how those changes alter the circuitry that controls cell behaviour.

By integrating functional assays with proteomics and phosphoproteomics, we aim to reconstruct signalling states in individual cancer populations and connect them to phenotype.

Read about our research →
WHAT WE INVESTIGATE
KEY CAPABILITIES
Cell-based screeningLC–MS/MSProteomicsPhosphoproteomicsKinase activityMachine learning
JOIN THE LAB

Build the next generation of cancer-signalling research with us.

We are building a multidisciplinary team at IPBLN-CSIC in Granada.

Explore opportunities →